Wormiza 222 mg is an effective oral anthelmintic used in the treatment of parasitic worm infections in humans. Formulated with the active ingredient Fenbendazole, it targets a wide spectrum of intestinal parasites including roundworms, hookworms, whipworms, and certain species of tapeworms. Though Fenbendazole is more commonly known for veterinary use, it has gained attention in human medicine under proper clinical supervision and specific treatment protocols.

Fenbendazole works by inhibiting the parasites' ability to absorb glucose, which is essential for their survival. This disruption leads to the death and eventual elimination of the worms from the body. The 222 mg dosage of Wormiza offers a convenient and potent single-dose or multi-day regimen, depending on the severity of the infection.

Wormiza is especially useful in regions where parasitic infections are endemic and can help restore gut health, enhance nutrient absorption, and support overall immune function. It is important to note that the use of Wormiza for human deworming should always be guided by a qualified healthcare professional to ensure safety and effectiveness.